Funding

The Mitton-Fry lab expresses its gratitude for research funding from the sources below.  We are also thankful for start-up funding from The Ohio State University College of Pharmacy and from the Discovery Themes Initiative.

 

Ongoing Research Support

 

NIH (NIAID) R01 Award

Mitton-Fry (PI) with Drs. Wozniak, Yalowich, Bell, Lindert, Kebriaei as co-investigators

Title: Overcoming Resistance to Novel Bacterial Topoisomerase Inhibitors

 

NIH (NCI) R01 Award [Nicholas Denko and Zihai Li, PIs]

Mitton-Fry (co-I)

Title: Overcoming Hypoxic Resistance to Anti-Cancer Therapy

 

NIH (NIAID) R01 Award [Daniel Wozniak, PI]

Mitton-Fry (co-I)

Title: The Impact of Bacteriophage Therapy on Wound Infection Dynamics

 

Infectious Diseases Institute at The Ohio State University Seed Grant [Brian Ahmer, contact PI]

Mitton-Fry (MPI)

Title: Optimizing Inhibitors of the Salmonella FraB Deglycase, a Novel Narrow Spectrum Drug Target

 

The Ohio State University President’s Research Excellence (PRE) Catalyst Award [Daniel Wozniak, contact PI]

Mitton-Fry (MPI)

Title: Combined Therapeutics for Combatting Antibiotic-Resistance Bacteria (CTCARB)

 

Ohio Development Services Agency

Mitton-Fry (PI)

Title: Preclinical Development of a New Antibacterial Therapy

 

Completed Research Support

 

Cystic Fibrosis Foundation Pilot and Feasibility Award            

Mitton-Fry (PI) with Drs. Wozniak and Yalowich as co-investigators                      11/2017-10/2019

Title: Novel Bacterial Type II Topoisomerase Inhibitors to Treat MRSA

 

Dr. Ralph and Marian Falk Medical Research Trust Catalyst Award                                          

Mitton-Fry (PI) with Drs. Lindert, McElroy, Wozniak, and Yalowich as co-investigators                       2/2018-11/2019

Title: Novel Therapies for MRSA and Innovative Methods for Tackling Bacterial Resistance

 

Cystic Fibrosis Foundation “NIH-Unfunded” Award

Mitton-Fry (PI) with Drs. Wozniak as co-investigator

              7/2020-8/2020 (original two-year award relinquished upon start of R21)

Title: Novel Bacterial Topoisomerase Inhibitors Targeting Gram-Negative Bacteria

 

Infectious Diseases Institute at The Ohio State University Seed Grant

Mitton-Fry (PI) with Drs. Wozniak, Wittum, and Parker as co-investigators

Title: Novel Bacterial Topoisomerase Inhibitors for Multidrug-Resistant Gonorrhea Infection

 

Dr. Ralph and Marian Falk Medical Research Trust Transformational Award              

Mitton-Fry (PI) with Drs. Lindert, McElroy, Wozniak, and Yalowich as co-investigators          11/2019-11/2022

Title: Combating Antibiotic Resistance with Novel Bacterial Topoisomerase Inhibitors

 

NIH (NIAID) R21 Award

Mitton-Fry (PI) with Drs. Wozniak, and Yalowich as co-investigators

Title: Novel Bacterial Topoisomerase Inhibitors Targeting Gram-Negative Bacteria

 

NIH (NIAID) R01 Award [Brian Ahmer and Venkat Gopalan, PIs]

Mitton-Fry (co-I)

Title: Salmonella-Specific Therapeutics

 

JobsOhio Early-Stage Technology Fund Award

Mitton-Fry (PI)

Preclinical Development of OSUAB-0284